STOCK TITAN

BoltRock lifts CitroTech (CITR) stake via note conversion and warrants

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

BoltRock Holdings LLC and Craig A. Huff report beneficial ownership of 4,183,743 CitroTech common shares, representing about 20.0% of the company. This total includes 3,357,467 existing shares, plus 318,914 shares issuable from 95,674 Series C Shares and 507,362 shares issuable from warrants held by BoltRock.

On April 7, 2026, CitroTech issued BoltRock a five-year warrant to purchase 46,250 shares at $3.00 per share in connection with extending the maturity of a Convertible Note. On April 28, 2026, CitroTech issued 940,799 shares to BoltRock upon converting $2,222,000 of principal plus accrued interest at a $2.40 per share conversion rate. BoltRock also appointed Huff to CitroTech’s board on October 21, 2025 under an existing securities purchase and stockholders agreement.

Positive

  • None.

Negative

  • None.

Insights

BoltRock’s 20% stake and board seat highlight a concentrated, actively structured position in CitroTech.

BoltRock Holdings LLC and Craig A. Huff now report beneficial ownership of 4,183,743 CitroTech common shares, about 20.0% of outstanding shares. The stake blends existing common stock, Series C convertible shares, and warrants, signaling a multi-instrument capital structure exposure.

CitroTech issued 940,799 shares on April 28, 2026 upon conversion of a Convertible Note for $2,222,000 in principal plus interest at $2.40 per share, and granted a warrant for 46,250 shares at $3.00 per share on April 7, 2026. Huff’s October 21, 2025 board appointment under a securities purchase and stockholders agreement ties this financial stake to formal governance influence.

Beneficial ownership 4,183,743 common shares Total CitroTech shares beneficially owned by Reporting Persons
Ownership percentage 20.0% Percent of CitroTech common stock represented by 4,183,743 shares
Shares outstanding 19,150,234 shares CitroTech common shares outstanding per Schedule 14C used in calculation
Convertible Note conversion shares 940,799 shares Shares issued to BoltRock on April 28, 2026 upon note conversion
Convertible Note principal $2,222,000 Outstanding principal converted to CitroTech shares at $2.40 per share
Conversion rate $2.40 per share Price used to convert Convertible Note into 940,799 shares
New warrant size 46,250 shares at $3.00 CitroTech warrant issued April 7, 2026 with five-year term
Series C conversion shares 318,914 shares Common shares issuable upon conversion of 95,674 Series C Shares
beneficial ownership financial
"The Reporting Persons have beneficial ownership of 4,183,743 Common Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Convertible Note financial
"upon the conversion of the Convertible Note for the outstanding principal amount of $2,222,000"
A convertible note is a type of loan that a company gets from investors, which can later be turned into company shares instead of being paid back in cash. It matters because it helps startups raise money quickly without setting a fixed value for the company right away, making it easier to grow and attract investors.
Series C Shares financial
"318,914 Common Shares issuable upon the conversion of 95,674 Series C Shares"
warrants financial
"507,362 Common Shares issuable upon the exercise of certain warrants held by BoltRock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
securities purchase and stockholders agreement financial
"pursuant to the terms of the securities purchase and stockholders agreement with TC Special Investments, LLC"
Schedule 13D regulatory
"This Amendment No. 2 to amends and supplements the statement on originally filed"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.





369759204

(CUSIP Number)
BoltRock Holdings LLC
712 5th Avenue, 22nd Floor,
New York, NY, 10019
(212) 735-2691

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
04/28/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


BoltRock Holdings LLC
Signature:/s/ Craig A. Huff
Name/Title:Managing Member
Date:04/30/2026
Craig A. Huff
Signature:/s/ Craig A. Huff
Name/Title:Craig A. Huff
Date:04/30/2026

FAQ

How many CitroTech (CITR) shares do BoltRock Holdings and Craig A. Huff beneficially own?

BoltRock Holdings LLC and Craig A. Huff beneficially own 4,183,743 CitroTech common shares. This includes 3,357,467 existing shares plus 318,914 shares issuable from 95,674 Series C Shares and 507,362 shares issuable upon exercise of certain warrants held by BoltRock.

What percentage of CitroTech (CITR) does BoltRock’s 4,183,743 shares represent?

Their 4,183,743 CitroTech common shares represent approximately 20.0% of the company’s outstanding common stock. The percentage is based on 19,150,234 shares outstanding, plus additional shares issuable from BoltRock’s Series C holdings, warrants, and the Convertible Note conversion.

How did BoltRock increase its CitroTech (CITR) stake through the Convertible Note?

On April 28, 2026, CitroTech issued BoltRock 940,799 common shares upon converting a Convertible Note. The conversion covered $2,222,000 of principal plus accrued and unpaid interest at a conversion rate of $2.40 per share, expanding BoltRock’s equity position in the company.

What are the key terms of the warrant CitroTech issued to BoltRock Holdings?

On April 7, 2026, CitroTech issued BoltRock a warrant to purchase 46,250 common shares at an exercise price of $3.00 per share. The warrant has a five-year term starting on its issuance date, adding potential future equity exposure for BoltRock if exercised.

How is BoltRock’s CitroTech (CITR) stake structured between common stock, Series C, and warrants?

BoltRock’s 4,183,743 beneficially owned shares consist of 3,357,467 common shares, 318,914 common shares issuable from 95,674 Series C Shares, and 507,362 common shares issuable upon the exercise of certain warrants. This mix combines current ownership with additional contingent equity rights.

Does Craig A. Huff have a governance role at CitroTech (CITR)?

Yes. On October 21, 2025, BoltRock appointed Craig A. Huff to CitroTech’s board of directors. The appointment was made pursuant to a securities purchase and stockholders agreement with TC Special Investments, LLC, aligning BoltRock’s significant ownership with board-level representation.